Occult central nervous system (CNS) involvement in patients (pts.) with metastatic breast cancer: prevalence, predictive factors and impact on overall survival.

被引：0
|
作者：
Miller, KD
Weathers, T
Haney, LG
Timmerman, R
Dickler, M
Shen, J
Sledge, GW
机构：
[1] Indiana Univ, Indianapolis, IN 46204 USA
[2] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2001年 / 69卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
214
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [1] Occult central nervous system involvement in patients with metastatic breast cancer: prevalence, predictive factors and impact on overall survival
    Miller, KD
    Weathers, T
    Haney, LG
    Timmerman, R
    Dickler, M
    Shen, J
    Sledge, GW
    [J]. ANNALS OF ONCOLOGY, 2003, 14 (07) : 1072 - 1077
  • [2] The clinical landscape of central nervous system (CNS) involvement in metastatic triple-negative breast cancer (TNBC) patients (pts)
    Eiger, D.
    de Azambuja, E.
    Moreau, M.
    Bondele, J.
    Sotiriou, C.
    Franzoi, M. A.
    Brandao, M. D. R. A.
    Rediti, M.
    Wang, X.
    Awada, A. H.
    Kotecki, N.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S73 - S74
  • [3] Central nervous system (CNS) metastases (mets) in HER2+metastatic breast cancer (MBC) patients (pts): Patterns of relapse and impact on survival
    Verma, S.
    Azzi, J. S.
    Vandermeer, L. A.
    Spaans, J. N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Risk factors for central nervous system metastasis in patients with metastatic breast cancer
    Sezgin, Canfeza
    Gokmen, Erhan
    Esassolak, Mustafa
    Ozdemir, Necmettin
    Goker, Erdem
    [J]. MEDICAL ONCOLOGY, 2007, 24 (02) : 155 - 161
  • [5] Risk factors for central nervous system metastasis in patients with metastatic breast cancer
    Canfeza Sezgin
    Erhan Gokmen
    Mustafa Esassolak
    Necmettin Ozdemir
    Erdem Goker
    [J]. Medical Oncology, 2007, 24 : 155 - 161
  • [6] CENTRAL NERVOUS INVOLVEMENT (CNI) IN PATIENTS WITH METASTATIC BREAST-CANCER
    LENZ, HJ
    ROOS, UM
    SCHMIDT, B
    STEINKE, B
    WALLER, HD
    [J]. TUMORDIAGNOSTIK & THERAPIE, 1991, 12 (05) : 211 - 214
  • [7] Natural history of seizures and the role of anticonvulsants (AC) in patients (Pts) with primary and metastatic central nervous system (CNS) cancer
    Cobb, JL
    Lekos, A
    Cole, BF
    Recht, L
    Mills, PC
    Glantz, MJ
    [J]. NEUROLOGY, 1997, 48 (03) : V1006 - V1006
  • [8] Risk factors for outcome in Hispanic patients with breast cancer with central nervous system (CNS) metastases
    Schwarz, L. J.
    Vidaurre, T.
    Neciosup, S. P.
    Pinto, J. A.
    Ferreyros, G.
    Gomez, H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [9] Prognostic factors for overall survival (OS) in metastatic melanoma (MM) patients (pts) treated with immune checkpoint inhibitors: A single institution study of 696 pts.
    McKean, Meredith Ann
    Haydu, Lauren Elaine
    Ma, Junsheng
    Bassett, Roland L.
    Hwu, Wen-Jen
    Patel, Sapna Pradyuman
    Diab, Adi
    Glitza, Isabella Claudia
    Tawbi, Hussein Abdul-Hassan
    Wong, Michael K.
    McQuade, Jennifer Leigh
    Hwu, Patrick
    Davies, Michael A.
    Amaria, Rodabe Navroze
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] Predictive factors for metastatic involvement of nonsentinel nodes in patients with breast cancer
    Rahusen, FD
    Torrenga, H
    van Diest, PJ
    Pijpers, R
    van der Wall, E
    Licht, J
    Meijer, S
    [J]. ARCHIVES OF SURGERY, 2001, 136 (09) : 1059 - 1063
12345